Anthem Biosciences

Anthem Biosciences

730.55
+0.95
(0.13%)
Market Cap
41,028.42 Cr
EPS
8.07
PE Ratio
90.81
Dividend Yield
0.00 %
Industry
-
52 Week High
801.85
52 Week Low
701.90
PB Ratio
17.01
Debt to Equity
0.08
Sector
-
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Forecast
Actual
Growth Rate
Revenue Growth
-
Net Income Growth
-
Cash Flow Change
198.49 %
ROE
-
ROCE
-
EBITDA Margin (Avg.)
-

Yearly Financial Results

Annual Financials
2020
2021
2022
2023
2024
2025
TTM
Revenue
654
1,140
1,280
1,134
1,483
1,930
0
Expenses
451
696
666
628
914
1,174
0
EBITDA
203
445
614
506
569
757
0
Operating Profit %
29 %
37 %
46 %
41 %
36 %
36 %
0 %
Depreciation
62
62
58
64
82
89
0
Interest
20
17
10
7
10
10
0
Profit Before Tax
121
366
546
497
477
657
0
Tax
28
94
141
112
110
206
0
Net Profit
93
271
406
385
367
451
0
EPS in ₹
108.00
323.43
467.55
6.75
6.48
8.07
0.00

Balance Sheet

Balance Sheet
2020
2021
2022
2023
2024
2025
Total Assets
787
1,034
1,619
2,015
2,398
2,808
Fixed Assets
306
361
329
449
483
705
Current Assets
403
616
1,098
1,323
1,482
1,737
Capital Work in Progress
50
19
154
164
345
297
Investments
99
209
273
499
472
433
Other Assets
333
445
863
903
1,099
1,373
Total Liabilities
787
1,034
1,619
2,015
2,398
2,808
Current Liabilities
247
285
223
164
339
326
Non Current Liabilities
118
47
41
110
135
72
Total Equity
422
702
1,355
1,741
1,925
2,410
Reserve & Surplus
414
693
1,346
1,627
1,813
2,298
Share Capital
8
9
9
114
112
112

Cash Flow

Cash Flow
2020
2021
2022
2023
2024
2025
Net Cash Flow
9
18
308
-6
-159
133
Investing Activities
-109
-196
-205
-376
-222
-152
Operating Activities
166
278
333
306
140
418
Financing Activities
-48
-63
181
64
-77
-134

Share Holding

% Holding
Dec 2024
Jul 2025
Promoter
77.23 %
76.88 %
FIIs
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
Government
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
Others
22.77 %
23.12 %
No of Share Holders
16
761

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
13 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Aug 2025 749.65 730.15

Technical Indicators

RSI(14)
Neutral
49.80
ATR(14)
Less Volatile
31.97
STOCH(9,6)
Oversold
0.00
STOCH RSI(14)
Oversold
0.00
MACD(12,26)
Bearish
0.00
ADX(14)
Weak Trend
0.00
UO(9)
Bullish
0.00
ROC(12)
Downtrend And Accelerating
-3.52
WillR(14)
Neutral
-72.29

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
HSBC Midcap Fund Direct-Growth
1.35%
2111545
1.35%
1.35%
SBI MNC Direct Plan-Growth
1.96%
1600000
1.96%
1.96%
Axis ELSS Tax Saver Direct Plan-Growth
0.28%
1300649
0.28%
0.28%
HDFC Manufacturing Fund Direct - Growth
0.81%
1255450
0.81%
0.81%
SBI Healthcare Opportunities Fund Direct Plan-Growth
2.26%
1200000
2.26%
2.26%
HDFC Business Cycle Fund Direct - Growth
3.08%
1188001
3.08%
3.08%
Nippon India Pharma Fund Direct-Growth
0.92%
1058503
0.92%
0.92%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct - Growth
1.31%
1052636
1.31%
1.31%
HDFC Pharma And Healthcare Fund Direct - Growth
2.96%
755131
2.96%
2.96%
HSBC Large and Mid Cap Fund Direct - Growth
1.33%
754472
1.33%
1.33%
Motilal Oswal Balanced Advantage Fund Direct-Growth
4.05%
526318
4.05%
4.05%
HDFC ELSS Tax Saver Fund Direct Plan-Growth
0.23%
494578
0.23%
0.23%
Axis Midcap Direct Plan-Growth
0.11%
434525
0.11%
0.11%
Axis Small Cap Fund Direct-Growth
0.12%
415200
0.12%
0.12%
HDFC Innovation Fund Direct-Growth
1.25%
400095
1.25%
1.25%
Aditya Birla Sun Life ELSS Tax Saver Direct-Growth
0.18%
360520
0.18%
0.18%
Aditya Birla Sun Life Pharma & Healthcare Fund Direct-Growth
3.06%
350896
3.06%
3.06%
Aditya Birla Sun Life Equity Hybrid '95 Fund Direct-Growth
0.36%
350870
0.36%
0.36%
UTI Small Cap Fund Direct - Growth
0.50%
317340
0.50%
0.50%
HDFC MNC Fund Direct - Growth
3.24%
252808
3.24%
3.24%
UTI Healthcare Fund Direct-Growth
1.39%
210522
1.39%
1.39%
Motilal Oswal Manufacturing Fund Direct-Growth
2.06%
210000
2.06%
2.06%
HDFC Dividend Yield Fund Direct - Growth
0.21%
174772
0.21%
0.21%
Axis Business Cycles Fund Direct-Growth
0.53%
162577
0.53%
0.53%
Edelweiss Mid Cap Direct Plan-Growth
0.10%
148529
0.10%
0.10%